TY - JOUR
T1 - The correlation analysis of functional factors and age with Duchenne muscular dystrophy
AU - Jung, Il Young
AU - Chae, Jong Hee
AU - Park, Sue Kyung
AU - Kim, Je Ho
AU - Kim, Jung Yoon
AU - Kim, Sang Joon
AU - Bang, Moon Suk
PY - 2012/2
Y1 - 2012/2
N2 - Objective: To correlate existing evaluation tools with clinical information on Duchenne muscular dystrophy (DMD) patients following age and to investigate genetic mutation and its relationship with clinical function. Method: The medical records of 121 children with DMD who had visited the pediatric rehabilitation clinic from 2006 to 2009 were reviewed. The mean patient age was 9.9±3.4 years and all subjects were male. Collected data included Brooke scale, Vignos scale, bilateral shoulder abductor and knee extensor muscles power, passive range of motion (PROM) of ankle dorsi-flexion, angle of scoliosis, peak cough flow (PCF), fractional shortening (FS), genetic abnormalities, and use of steroid. Results: The Brooke and Vignos scales were linearly increased with age (Brooke (y1), Vignos (y2), age (x), y 1=0.345x-1.221, R Brooke 2=0.435, y 2=0.813x-3.079, R Vignos 2=0.558, p<0.001). In relation to the PROM of ankle dorsiflexion, there was a linear decrease in both ankles (right and left R 2=0.364, 0.372, p<0.001). Muscle power, Cobb angle, PCF, and FS showed diversity in their degrees, irrespective of age. The genetic test for dystrophin identified exon deletions in 58.0% (69/119), duplications in 9.2% (11/119), and no deletions or duplications in 32.8% (39/119). Statistically, the genetic abnormalities and use of steroid were not definitely associated with functional scale. Conclusion: The Brooke scale, Vignos scale and PROM of ankle dorsi-flexion were partially available to assess DMD patients. However, this study demonstrates the limitations of preexisting scales and clinical parameters incomprehensively reflecting functional changes of DMD patients.
AB - Objective: To correlate existing evaluation tools with clinical information on Duchenne muscular dystrophy (DMD) patients following age and to investigate genetic mutation and its relationship with clinical function. Method: The medical records of 121 children with DMD who had visited the pediatric rehabilitation clinic from 2006 to 2009 were reviewed. The mean patient age was 9.9±3.4 years and all subjects were male. Collected data included Brooke scale, Vignos scale, bilateral shoulder abductor and knee extensor muscles power, passive range of motion (PROM) of ankle dorsi-flexion, angle of scoliosis, peak cough flow (PCF), fractional shortening (FS), genetic abnormalities, and use of steroid. Results: The Brooke and Vignos scales were linearly increased with age (Brooke (y1), Vignos (y2), age (x), y 1=0.345x-1.221, R Brooke 2=0.435, y 2=0.813x-3.079, R Vignos 2=0.558, p<0.001). In relation to the PROM of ankle dorsiflexion, there was a linear decrease in both ankles (right and left R 2=0.364, 0.372, p<0.001). Muscle power, Cobb angle, PCF, and FS showed diversity in their degrees, irrespective of age. The genetic test for dystrophin identified exon deletions in 58.0% (69/119), duplications in 9.2% (11/119), and no deletions or duplications in 32.8% (39/119). Statistically, the genetic abnormalities and use of steroid were not definitely associated with functional scale. Conclusion: The Brooke scale, Vignos scale and PROM of ankle dorsi-flexion were partially available to assess DMD patients. However, this study demonstrates the limitations of preexisting scales and clinical parameters incomprehensively reflecting functional changes of DMD patients.
KW - Age
KW - Duchenne muscular dystrophy
KW - Dystrophin
KW - Function
KW - Gene deletion
UR - http://www.scopus.com/inward/record.url?scp=84861969780&partnerID=8YFLogxK
U2 - 10.5535/arm.2012.36.1.22
DO - 10.5535/arm.2012.36.1.22
M3 - Article
C2 - 22506232
AN - SCOPUS:84861969780
SN - 2234-0645
VL - 36
SP - 22
EP - 32
JO - Annals of Rehabilitation Medicine
JF - Annals of Rehabilitation Medicine
IS - 1
ER -